NCT03313973

Brief Summary

Lower respiratory tract infections are one of the main hospitalization or mortality cause in idiopathic Parkinson's disease. Because of akinesia and articular rigidity these patient develop restrictive syndrome by reduction in the thoraco-lung compliance.The consequence is a progressive loss of the aerobic physical abilities and infection. The myotensive technique of active muscular stretching seem to increase the range of motion in healthy subject but also in patient with chronic bronchiotisis . These technics also increase the vital respiratory capacity and re enforce the muscles.So adding these technics during the period when the Parkinson's disease patient is stable would be a way of improvement .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
Completed

Started Dec 2016

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 19, 2017

Completed
Last Updated

October 19, 2017

Status Verified

October 1, 2017

Enrollment Period

7 months

First QC Date

October 10, 2017

Last Update Submit

October 18, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage vital respiratory capacity

    4 weeks

Study Arms (2)

with self stretching same muscle

EXPERIMENTAL
Procedure: with self stretching same muscle

with self stretching forearm muscle

SHAM COMPARATOR
Procedure: with self stretching of forearm muscles

Interventions

with self stretching

with self stretching same muscle

without self stretching

with self stretching forearm muscle

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18
  • with Parkinson's disease
  • stable stade of pathology
  • without any treatment modification.

You may not qualify if:

  • rehabilitation support or osteopathic support
  • active smoking
  • respiratory disease
  • cognitives trouble
  • any other neurologic pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, 75014, France

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2017

First Posted

October 19, 2017

Study Start

December 5, 2016

Primary Completion

June 30, 2017

Study Completion

July 31, 2017

Last Updated

October 19, 2017

Record last verified: 2017-10

Locations